Mylan Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?
MYLAN PHARMS INC has forty-two approved drugs.
There are eighteen tentative approvals on MYLAN PHARMS INC drugs.
Summary for Mylan Pharms Inc
| US Patents: | 0 |
| Tradenames: | 39 |
| Ingredients: | 39 |
| NDAs: | 42 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 070791-005 | May 13, 1986 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Pharms Inc | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 201993-002 | Dec 31, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Pharms Inc | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 091226-001 | May 29, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Pharms Inc | VORICONAZOLE | voriconazole | TABLET;ORAL | 090547-002 | Apr 22, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Pharms Inc | ARMODAFINIL | armodafinil | TABLET;ORAL | 200043-003 | Jun 1, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Pharms Inc | ESZOPICLONE | eszopiclone | TABLET;ORAL | 091151-002 | Mar 26, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 4,971,800 | ⤷ Sign Up |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 5,045,317 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
